Carbon nanotubes as delivery systems for respiratory disease: Do the dangers outweigh the potential benefits?

Expert Review of Respiratory Medicine

Volumn 5, Issue 6, 2011, Pages 779-787

  Bonner, James C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Carbon nanotubes; Disease risk; Drug delivery; Health benefits; Nanoparticles

Indexed keywords

CARBON NANOTUBE; MULTI WALLED NANOTUBE; REACTIVE OXYGEN METABOLITE; SINGLE WALLED NANOTUBE;

ASTHMA; BACTERIAL INFECTION; BIODEGRADABILITY; CARCINOGENICITY; DISEASE EXACERBATION; DRUG DELIVERY SYSTEM; FIBROGENESIS; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; LUNG FIBROSIS; PLEURA DISEASE; PNEUMONIA; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; RISK BENEFIT ANALYSIS;

EID: 81255157042     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.11.72     Document Type: Review

References (64)

1. De Jong WH, Borm PH. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomedicine 3(2), 133-149 (2008). (Pubitemid 352042401)
2. Card JW, Zeldin DC, Bonner JC, Nestmann ER. Pulmonary applications and toxicity of engineered nanoparticles. Am. J. Physiol. 295(3), L400-L411 (2008).
3. Bonner JC, Card JW, Zeldin DC. Nanoparticle-mediated drug delivery and pulmonary hypertension. Hypertension 53, 751-753 (2009).
4. Prato M, Kostarelos K, Bianco A. Functionalized carbon nanotubes in drug design and discovery. Acc. Chem. Res. 41(1), 60-68 (2008).
5. Donaldson K, Murphy F, Schinwald A et al. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine (Lond. ) 6(1), 143-156 (2011).
6. Wick P, Clift MJ, RÖsslein M, Rothen-Rutishauser B. A brief summary of carbon nanotubes science and technology: a health and safety perspective. ChemSusChem. 4(7), 905-911 (2011).
7. Kaiser JP, Roesslein M, Buerki-Thurnherr T et al. Carbon nanotubes - curse or blessing. Curr. Med. Chem. 18(14), 2115-2128 (2011).
8. Nel AE, Mdler L, Velegol D et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8(7), 543-557 (2009).
9. Hirsch C, Roesslein M, Krug HF et al. Nanomaterial cell interactions: are current in vitro tests reliable?. Nanomedicine (Lond. ) 6(5), 837-847 (2011).
10. George S, Pokhrel S, Xia T et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 4(1), 15-29 (2010).
11. Bonner JC. Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc. Am. Thorac. Soc. 7(2), 138-141 (2010).
12. Konduru NV, Tyurina YY, Feng W et al. Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS ONE 4(2), e4398 (2009).
13. Mangum JB, Turpin EA, Antao-Menezes A et al. Single-walled carbon nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages in situ. Part. Fibre Toxicol. 3, 15 (2006).
14. Ryman-Rasmussen JP, Cesta MF, Brody AR et al. Inhaled multi-walled carbon nanotubes reach the subpleural tissue in mice. Nat. Nanotechnol. 4(11), 747-751 (2009).
15. Borm PJ, Robbins D, Haubold S et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part. Fibre Toxicol. 3, 11 (2006).
16. Donaldson K, Aitken R, Tran L et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 92(1), 5-22 (2006). (Pubitemid 43985785)
17. Donaldson K, Murphy FA, Duffin R et al. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part. Fibre Toxicol. 7, 5 (2010).
18. Pauluhn J. Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. Toxicol. Sci. 113(1), 226-242 (2010).
19. Thurnherr T, Brandenberger C, Fischer K et al. A comparison of acute and long-term effects of industrial multiwalled carbon nanotubes on human lung and immune cells in vitro. Toxicol. Lett. 200(3), 176-186 (2011).
20. Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, McDonald JD. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol. Sci. 100, 203-214 (2007). (Pubitemid 47617817)
21. Tkach AV, Shurin GV, Shurin MR et al. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano 5(7), 5755-5762 (2011).
22. Kunzmann A, Andersson B, Thurnherr T et al. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution, and biodegradation. Biochim. Biophys. Acta 1810(3), 361-373, (2011).
23. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77, 126-134 (2004). (Pubitemid 38128652)
24. Muller J, Huaux F, Moreau N et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 207, 221-231 (2005). (Pubitemid 41207915)
25. Shvedova AA, Kisin ER, Mercer R et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L698-L708 (2005). (Pubitemid 41504399)
26. Warheit DB, Laurence BR, Reed KL et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 77, 117-125 (2004). (Pubitemid 38128651)
27. Mercer RR, Scabilloni J, Wang, L et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am. J. Physiol. Lung Cell Mol. Physiol. 294, L87-L97 (2008). (Pubitemid 351380321)
28. Li JG, Li WX, Xu JY et al. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation. Environ. Toxicol. 22, 415-421 (2007).
29. Wang X, Xia T, Ntim SA et al. Quantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cells. ACS Nano 4(12), 7241-7252 (2010).
30. Anderson PJ, Wilson JD, Hiller FC. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest 97(5), 1115-1120 (1990). (Pubitemid 20166800)
31. Ryman-Rasmussen JP, Tewksbury EW, Moss OR et al. Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in a murine model of allergic asthma. Am. J. Resp. Cell Mol. Biol. 40(3), 349-358 (2009).
32. Inoue K, Koike E, Yanagisawa R et al. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol. Appl. Pharmacol. 237(3), 306-316 (2009).
33. Inoue K, Yanagisawa R, Koike E et al. Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: possible role of oxidative stress. Free Radic. Biol. Med. 48(7), 924-934 (2010).
34. Park EJ, Cho WS, Jeong J et al. Proinflammatory and potential allergic responses resulting from B cell activation in mice treated with multi-walled carbon nanotubes by intratracheal instillation. Toxicology 259(3), 113-121 (2009).
35. Nygaard UC, Hansen JS, Samuelsen M et al. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicol. Sci. 109(1), 113-123 (2009).
36. Wang X, Katwa P, Podila R et al. Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6mice. Part Fibre Toxicol. 8(1), 24 (2011).
37. Gavett SH, Koren HS. The role of particulate matter in exacerbation of atopic asthma. Int. Arch. Allergy Immunol. 124(1-3), 109-112 (2001). (Pubitemid 32304778)
38. Hussain S, Vanoirbeek JA, Luyts K et al. Lung exposure to nanoparticles modulates an asthmatic response in a mouse model of asthma. Eur. Respir. J. 37(2), 299-309 (2011).
39. Ryan JJ, Bateman HR, Stover A et al. Fullerene nanomaterials inhibit the allergic response. J Immunol. 179, 665-672 (2007). (Pubitemid 46986585)
40. Inoue K, Takano H, Koike E et al. Effects of pulmonary exposure to carbon nanotubes on lung and systemic inflammation with coagulatory disturbance induced by lipopolysaccharide in mice. Exp. Biol. Med. 233(12), 1583-1590 (2008).
41. Cesta MF, Ryman-Rasmussen JP, Wallace et al. Bacterial lipopolysaccharide enhances PDGF signaling and pulmonary fibrosis in rats exposed to carbon nanotubes. Am. J. Respir. Cell Mol. Biol. 43(2), 142-151 (2010).
42. Shvedova AA, Fabisiak JP, Kisin ER, et al. Sequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivity. Am. J. Respir. Cell Mol. Biol. 38, 579-590 (2008). (Pubitemid 351758677)
43. Jaspers I, Sheridan PA, Zhang W et al. Exacerbation of allergic inflammation in mice exposed to diesel exhaust particles prior to viral infection. Part. Fibre Toxicol. 6, 22 (2009).
44. Erdely A, Hulderman T, Salmen R et al. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 9(1), 36-43 (2009).
45. Li Z, Hulderman T, Salmen R et al. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ. Health Perspect. 115, 377-382 (2007). (Pubitemid 46554435)
46. Mitchell LA, Lauer FT, Burchiel SW et al. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat. Nanotech. 4(7), 451-456 (2009).
47. Sargent LM, Shvedova AA, Hubbs A et al. Induction of aneuploidy by single-walled carbon nanotubes. Environ. Mol. Mutagen. 50(8), 708-717 (2009).
48. Zhu L, Chang DW, Dai L et al. DNA damage induced by multiwalled carbon nanotubes in mouse embryonic stem cells. Nano Lett. 7(12), 3592-3597 (2007).
49. Yamashita K, Yoshioka Y, Higashisaka K et al. Carbon nanotubes elicit DNA damage and inflammatory response relative to their size and shape. Inflammation 33(4), 276-280 (2010).
50. Patlolla AK, Hussain SM, Schlager JJ et al. Comparative study of the clastogenicity of functionalized and non-functionalized multi-walled carbon nanotubes in bone marrow cells of Swiss-Webster mice. Environ. Toxicol. 25(6), 608-621 (2010).
51. Zhang Y, Xu Y, Li Z et al. Mechanistic toxicity evaluation of uncoated and pegylated single-walled carbon nanotubes in neuronal PC12 cells. ACS Nano 5(9), 7020-7033 (2011).
52. Poland CA, Duffin R, Kinloch I et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestoslike pathogenicity in a pilot study. Nat. Nanotechnol. 3(7), 423-428 (2008).
53. Porter DW, Hubbs AF, Mercer RR et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 269(2-3), 136-147 (2010).
54. Mercer RR et al. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part. Fibre Toxicol. 7, 28 (2010).
55. Murphy FA. Poland CA, Duffin R et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am. J. Pathol. 178, 2587-2600, (2011).
56. Shvedova AA, Kisin ER, Porter D et al. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus?. Pharmacol. Ther. 121(2), 192-204 (2009).
57. Johnston HJ, Hutchison GR, Christensen FM et al. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: the contribution of physico-chemical characteristics. Nanotoxicology 4(2), 207-246 (2010)
58. Kagan VE, Konduru NV, Feng W et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat Nanotechnol. 5(5), 354-359 (2010).
59. Allen BL, Kotchey GP, Chen Y, et al. Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes. J. Am. Chem. Soc. 131(47), 17194-17205 (2009).
60. Wang L, Castranova V, Mishra A et al. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part. Fibre Toxicol. 19(7), 31 (2010).
61. Kreyling WG, Hirn S, Schleh C. Nanoparticles in the lung. Nat Biotechnol. 28(12), 1275-1276 (2010).
62. McDevitt MR, Chattopadhyay D, Kappel BJ et al. Tumor targeting with antibodyfunctionalized, radiolabeled carbon nanotubes. J. Nucl. Med. 48(7), 1180-1189 (2007). (Pubitemid 47052659)
63. Chakravarty P, Marches R, Zimmerman NS et al. Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes. Proc. Natl Acad. Sci. USA 105(25), 8697-8702 (2008). (Pubitemid 351987743)
64. Hodgson E. A Textbook of Modern Toxicology, 4th Edition. John Wiley and Sons, Inc. , NJ, USA, 648 (2010).